Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial - McInnes, I B; Kavanaugh, A; Gottlieb, A B; PSUMMIT 1 Study Group (Lancet, 2013)